栄養補助食品成分市場:タイプ別(プロバイオティクス、タンパク質、アミノ酸、植物化学物質と植物抽出物、繊維と特殊炭水化物)、用途別(食品、飲料、動物栄養、栄養補助食品)、形態と地域 - 2027年までの世界予測Nutraceutical Ingredients Market by Type (Probiotics, Proteins, Amino Acids, Phytochemicals & Plant Extracts, Fibers & Specialty Carbohydrates), Application (Food, Beverages, Animal Nutrition, Dietary Supplements), Form & Region - Global Forecast to 2027 2022年の栄養補助食品成分市場は1,852億米ドルと推定され、2027年には年平均成長率7.2%で2,617億米ドルに達すると予測されています。栄養補助食品成分は、健康の増進、慢性疾患の予防、寿命の延長、老化の抑制、... もっと見る
サマリー2022年の栄養補助食品成分市場は1,852億米ドルと推定され、2027年には年平均成長率7.2%で2,617億米ドルに達すると予測されています。栄養補助食品成分は、健康の増進、慢性疾患の予防、寿命の延長、老化の抑制、体内システムのサポートなどを目的として使用される物質です。栄養補助食品成分は、治療というよりも予防の手段として捉えられている。これらの成分は特定の問題に作用するため、製品の配合成分として頻繁に使用される。食品、飲料、栄養補助食品、動物栄養、パーソナルケアなどの業界は、その製品処方に最も適用されるものの一部です。これらの製品は、栄養面での利点や人々のライフスタイルへの適合性から、市場でより人気が高まっている。免疫力強化、骨と健康、心臓血管の健康、精神的な健康、幼児栄養、体重減少管理、その他の栄養補助食品は現在人気があります。ここ数年、人々の健康やホリスティック・ウェルネスに対する意識が高まっています。また、国民の大多数が速いペースで生活していることも、栄養補助食品市場の拡大に影響しています。タイプ別のプロバイオティクス栄養補助食品は、予測期間を通じて栄養補助食品成分市場の金額で最高の市場シェアを有すると予測されています。 増加する技術の改善と科学の進歩は、過去20年間でプロバイオティクス業界を成長させました。プロバイオティクス株は、これらの株が成長するための特別な環境&培地、温度を必要とし、培養に長い時間がかかることができ、培養プロセスをスピードアップすることができないため、製造が困難で高価であると考えられている。また、プロバイオティクスは近年人気が高まっており、その健康効果から、近い将来、栄養補助食品市場でも成長すると予想されている。 アプリケーション別の食品セグメントは、世界の栄養補助食品成分市場で最高の市場シェアを有すると予測される。 主要企業は、広範囲に栄養補助食品製品の製品開発と技術革新に投資している。企業は、より良い食品ソリューションを見つけるために、顧客をターゲットとし、そのニーズを理解してきました。消費者の健康志向や意識が高まるにつれ、バランスの取れた食事や健康的な食品への嗜好が高く保たれている。そして、その口当たりの良さ、口当たり、食感の良さが理由です。このことを考慮し、食品メーカーは健康的な代替品となり得る製品の革新を開始した。したがって、栄養補助食品成分市場において、これらの市場はより多くの市場シェアを獲得すると推定される。 乾燥成分は、フォームによって、予測期間を通して栄養補助食品成分市場で最も速い市場成長を達成することが予測される 栄養補助食品成分の乾燥形態の広いアプリケーションは、液体形態と比較して、その高い市場シェアの主要な要因となっています。栄養補助食品製品の処方のほとんどは、製品の処方にも依存する成分の乾燥形態を使用しています。乾燥成分は、液状のものに比べて安定性が高く、保存期間も長くなります。したがって、乾燥食品は急速に成長すると予測される。 主な内訳 - 企業タイプ別ティア1:25%、ティア2:35%、ティア3:40%。 - 役職別役員クラス:30%、Cクラス:25%、マネージャークラス:45 - 地域別欧州:28%、アジア太平洋:33%、北米:17%、RoW:22 本レポートに掲載されている主要なプレイヤー - アソシエイテッド・ブリティッシュ・フーズ Plc(英国) - Arla Foods Ingredients Group P/S(デンマーク) - DSM (オランダ) - イングレディオン(米国) - テート&ライル(イギリス) - 味の素株式会社(日本) - CHR Hansen Holdings A/S.(デンマーク) - 協和発酵バイオ株式会社(日本日本 - Glanbia Plc(アイルランド) - フォンテラ Co.Operative Group Limited(ニュージーランド) - カーギルインコーポレイテッド(米国) - ADM(米国) - International Flavors & Fragrances, Inc.(米国) - BASF SE (ドイツ) - ケリーグループ(アイルランド) 調査対象 本レポートでは、栄養補助食品成分市場を成分の種類、用途、健康効果、地域に基づいて分類しています。本調査レポートでは、競合環境、最終用途分析、企業プロファイルといった様々なレベルの分析に焦点を当て、栄養補助食品成分市場の新興&高成長セグメント、高成長地域、国、政府の取り組み、市場の混乱、促進要因、阻害要因、機会、課題に関する基本見解を構成・考察しています。 本レポートを購入する理由 - 栄養補助食品成分市場の包括的な概観を得るため - この業界のトッププレーヤー、その製品ポートフォリオ、およびそれらによって採用される主要な戦略に関する広範な情報を取得するために - 栄養補助食品成分市場が繁栄している主要国/地域についての洞察を得るために。 目次1 INTRODUCTION 381.1 STUDY OBJECTIVES 38 1.2 MARKET DEFINITION 38 1.3 STUDY SCOPE 39 1.3.1 MARKETS COVERED 39 FIGURE 1 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT 39 1.3.2 GEOGRAPHIC SEGMENTATION 40 FIGURE 2 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 40 1.4 INCLUSIONS & EXCLUSIONS 40 1.5 YEARS CONSIDERED 41 1.6 CURRENCY CONSIDERED 41 TABLE 1 US DOLLAR EXCHANGE RATES CONSIDERED, 2013–2018 42 1.7 UNIT CONSIDERED 42 1.8 STAKEHOLDERS 42 1.9 SUMMARY OF CHANGES 43 2 RESEARCH METHODOLOGY 44 2.1 RESEARCH DATA 44 FIGURE 3 NUTRACEUTICAL INGREDIENTS: RESEARCH DESIGN 44 2.1.1 SECONDARY DATA 45 2.1.1.1 Key data from secondary sources 45 2.1.2 PRIMARY DATA 45 2.1.2.1 Key industry insights 46 2.1.2.2 Breakdown of primary interviews 46 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46 2.2 MARKET SIZE ESTIMATION 47 2.2.1 BOTTOM-UP 47 FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 48 2.2.2 TOP-DOWN 48 FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 49 2.2.3 SUPPLY-SIDE 49 FIGURE 7 DATA TRIANGULATION: SUPPLY-SIDE 50 2.2.4 DEMAND-SIDE 50 FIGURE 8 DATA TRIANGULATION: DEMAND-SIDE 51 2.3 DATA TRIANGULATION 52 FIGURE 9 DATA TRIANGULATION 52 2.4 RESEARCH ASSUMPTIONS & LIMITATIONS 53 2.4.1 ASSUMPTIONS 53 2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS 54 3 EXECUTIVE SUMMARY 55 TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT, 2022 VS. 2027 55 FIGURE 10 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION) 56 FIGURE 11 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION) 57 FIGURE 12 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (USD BILLION) 57 FIGURE 13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 58 4 PREMIUM INSIGHTS 59 4.1 ATTRACTIVE OPPORTUNITIES IN NUTRACEUTICAL INGREDIENTS MARKET 59 FIGURE 14 INCREASED CONSUMPTION OF FORTIFIED FOODS DUE TO GROWING HEALTH CONSCIOUSNESS AMONG CONSUMERS 59 4.2 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY 60 FIGURE 15 INDIA AND PROBIOTICS ACCOUNTED FOR LARGEST SHARES, BY COUNTRY AND TYPE, RESPECTIVELY 60 4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SUBMARKETS 60 FIGURE 16 JAPAN TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 60 4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION 61 FIGURE 17 ASIA PACIFIC TO DOMINATE NUTRACEUTICAL INGREDIENTS MARKET ACROSS ALL TYPES 61 4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM 62 FIGURE 18 DRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 62 4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 62 FIGURE 19 DIETARY SUPPLEMENTS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 62 5 MARKET OVERVIEW 63 5.1 INTRODUCTION 63 5.2 MACROECONOMIC INDICATORS 63 5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY 63 5.2.2 KEY FACTS 63 5.2.2.1 Aging population becoming more aware of benefits of nutraceuticals 64 FIGURE 20 US POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION) 65 FIGURE 21 AGING POPULATION IN JAPAN, 2014–2018 65 5.3 MARKET DYNAMICS 66 FIGURE 22 NUTRACEUTICAL INGREDIENTS: MARKET DYNAMICS 66 5.3.1 DRIVERS 66 5.3.1.1 Growing demand for fortified food due to increased health consciousness among consumers 66 FIGURE 23 CONSUMERS' PERCEPTION REGARDING WHAT TO CONSUME OR AVOID 68 5.3.1.2 Increase in incidences of chronic diseases 68 FIGURE 24 PERCENTAGE OF US POPULATION WITH MULTIPLE CHRONIC ILLNESSES, 2017 69 FIGURE 25 CHRONIC DISEASES MOST PREVALENT WORLDWIDE AMONGST ALL AGES, 2019 69 FIGURE 26 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS 70 5.3.1.3 Mandates on food fortification by government organizations 71 TABLE 3 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION 72 TABLE 4 WIDELY USED FORTIFIED FOODS 73 FIGURE 27 NUMBER OF COUNTRIES WITH MANDATORY OR VOLUNTARY FOOD FORTIFICATION, 2021 73 5.3.2 RESTRAINTS 74 5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption 74 5.3.3 OPPORTUNITIES 75 5.3.3.1 Innovations in nutraceutical ingredients industry 75 5.3.3.2 Consumer awareness of micronutrient deficiencies 77 TABLE 5 FOODS TO BOOST IMMUNE SYSTEM 78 TABLE 6 MICRONUTRIENTS DEFICIENCY CONDITIONS AND THEIR WORLDWIDE PREVALENCE 78 5.3.4 CHALLENGES 78 5.3.4.1 Consumer skepticism associated with nutraceutical products 78 6 INDUSTRY TRENDS 80 6.1 INTRODUCTION 80 6.2 VALUE CHAIN ANALYSIS 81 FIGURE 28 VALUE CHAIN: NUTRACEUTICAL INGREDIENTS MARKET 81 6.2.1 SOURCING OF RAW MATERIALS 81 6.2.2 MANUFACTURING 82 6.2.3 DISTRIBUTION, MARKETING, AND SALES 82 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82 FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL INGREDIENTS MARKET 82 6.4 TECHNOLOGY ANALYSIS 83 6.4.1 FOOD MICROENCAPSULATION 83 6.4.1.1 Encapsulation of omega-3 to mask the odor 83 6.4.2 INNOVATIVE AND DISRUPTIVE TECH 84 6.4.2.1 Robotics leading to innovations in market 84 6.4.2.2 3D printing to uplift dietary supplements market 84 6.4.2.3 Hologram Sciences—platform for personalized nutrition and advice 84 6.5 PRICING ANALYSIS 85 FIGURE 30 PRICING ANALYSIS, 2017–2022 (USD/KG) 85 6.6 PATENT ANALYSIS 85 FIGURE 31 PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021 86 FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021 86 TABLE 7 KEY PATENTS PERTAINING NUTRACEUTICAL INGREDIENTS MARKET, 2021 87 6.7 MARKET MAP 88 6.7.1 UPSTREAM 88 6.7.1.1 Ingredient Manufacturers 88 6.7.1.2 Technology Providers 88 6.7.1.3 Start-ups/Emerging Companies 88 6.7.2 DOWNSTREAM 89 6.7.2.1 Regulatory Bodies 89 6.7.2.2 End Users 89 FIGURE 33 NUTRACEUTICALS INGREDIENTS MARKET MAP 90 TABLE 8 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM 90 6.8 TRADE SCENARIO 92 FIGURE 34 VITAMINS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 92 TABLE 9 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2021 (VALUE) 93 FIGURE 35 VITAMINS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 93 TABLE 10 EXPORT DATA ON VITAMINS FOR KEY COUNTRIES, 2021 (VALUE) 94 FIGURE 36 AMINO ACIDS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 94 TABLE 11 IMPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE) 95 FIGURE 37 AMINO ACIDS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 95 TABLE 12 EXPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE) 96 6.9 KEY CONFERENCES & EVENTS IN 2022–2023 96 TABLE 13 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2022–2023 96 6.10 TARIFF AND REGULATORY LANDSCAPE 98 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 6.10.2 REGULATORY FRAMEWORK 102 6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market 102 TABLE 19 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE 103 6.10.2.2 North America 104 6.10.2.2.1 Canada 104 6.10.2.2.2 US 104 6.10.2.2.3 Mexico 104 6.10.2.3 European Union (EU) 104 6.10.2.4 Asia Pacific 105 6.10.2.4.1 Japan 105 6.10.2.4.2 China 105 6.10.2.4.3 India 105 6.10.2.4.4 Australia & New Zealand 105 6.10.2.5 Rest of the World (RoW) 106 6.10.2.5.1 Israel 106 6.10.2.5.2 Brazil 106 6.10.2.6 Probiotics 106 6.10.2.6.1 Introduction 106 6.10.2.6.2 National/International bodies for safety standards and regulations 106 TABLE 20 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE 106 6.10.2.6.3 Codex Alimentarius Commission (CAC) 107 6.10.2.6.4 North America: Regulatory environment analysis 107 6.10.2.6.5 Europe: Regulatory environment analysis 108 6.10.2.6.6 Asia Pacific: Regulatory environment analysis 109 6.10.2.6.7 South America: Regulatory environment analysis 110 6.10.2.7 Prebiotics 110 6.10.2.7.1 Introduction 110 6.10.2.7.2 Asia Pacific 110 TABLE 21 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015 111 6.10.2.7.3 North America 111 TABLE 22 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES 112 6.10.2.7.4 European Union 113 6.11 PORTER'S FIVE FORCES ANALYSIS 113 TABLE 23 NUTRACEUTICAL INGREDIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS 113 6.11.1 DEGREE OF COMPETITION 113 6.11.2 BARGAINING POWER OF SUPPLIERS 114 6.11.3 BARGAINING POWER OF BUYERS 114 6.11.4 THREAT OF SUBSTITUTES 114 6.11.5 THREAT OF NEW ENTRANTS 115 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 115 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 115 FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES 116 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES (%) 116 6.12.2 BUYING CRITERIA 116 TABLE 25 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 116 FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 117 6.13 CASE STUDY ANALYSIS 117 6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY 117 6.13.2 MINDRIGHT’S BARS HELP COMBAT MENTAL HEALTH ISSUES 118 7 NUTRACEUTICAL INGREDIENTS MARKET, BY HEALTH BENEFITS 119 7.1 INTRODUCTION 119 7.2 COGNITIVE HEALTH 119 7.3 GUT HEALTH 120 7.4 HEART HEALTH 120 7.5 BONE HEALTH 121 TABLE 26 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE 121 7.6 IMMUNITY 122 7.7 NUTRITION 122 7.8 WEIGHT MANAGEMENT 122 7.9 OTHERS 123 8 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE 124 8.1 INTRODUCTION 125 FIGURE 40 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (BY VALUE) 125 TABLE 27 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 126 TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 126 TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (KT) 127 TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (KT) 127 8.2 PROBIOTIC 128 8.2.1 HIGH DEMAND FOR SCIENTIFICALLY PROVEN HEALTH FOODS AND DIETARY SUPPLEMENTS 128 TABLE 31 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 130 TABLE 32 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 130 TABLE 33 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 130 TABLE 34 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 131 8.3 PROTEINS & AMINO ACIDS 131 8.3.1 IMPORTANT INGREDIENTS IN FOOD AND FEED INDUSTRIES 131 TABLE 35 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 133 TABLE 36 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 133 TABLE 37 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 133 TABLE 38 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 134 8.4 PHYTOCHEMICALS & PLANT EXTRACTS 134 8.4.1 GROWING DEMAND FOR ORGANIC FOOD PRODUCTS AND INGREDIENTS 134 TABLE 39 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS 135 TABLE 40 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 135 TABLE 41 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 135 TABLE 42 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 136 TABLE 43 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 136 8.5 FIBERS & SPECIALTY CARBOHYDRATES 136 8.5.1 ADDED TO FUNCTIONAL FOOD & BEVERAGES MORE FREQUENTLY 136 TABLE 44 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 137 TABLE 45 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 138 TABLE 46 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 138 TABLE 47 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 138 8.6 OMEGA-3 FATTY ACIDS 139 8.6.1 INCREASED USE OF OMEGA-3 TO ENHANCE HEART AND BRAIN HEALTH 139 TABLE 48 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 140 TABLE 49 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 140 TABLE 50 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 140 TABLE 51 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 141 8.7 VITAMINS 141 8.7.1 AWARENESS, WIDE ACCEPTANCE, AND EASY AVAILABILITY DRIVE DEMAND 141 TABLE 52 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 142 TABLE 53 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 142 TABLE 54 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 143 TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 143 8.8 PREBIOTICS 143 8.8.1 USED AS TEXTURE ENHANCEMENT AND SWEETENING AGENTS 143 TABLE 56 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 144 TABLE 57 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 145 TABLE 58 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 145 TABLE 59 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 145 8.9 CAROTENOIDS 146 8.9.1 GROWING FOOD ADDITIVES AND PERSONAL CARE INDUSTRIES TO PROPEL DEMAND 146 TABLE 60 SOURCES OF CAROTENOIDS IN FRUIT AND VEGETABLES AND THEIR MEDICINAL PROPERTIES 147 TABLE 61 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 147 TABLE 62 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 148 TABLE 63 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 148 TABLE 64 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 148 8.10 MINERALS 149 8.10.1 SEVERAL HEALTH ADVANTAGES ASSOCIATED WITH MINERALS 149 TABLE 65 MACROMINERALS & THEIR FUNCTIONS 150 TABLE 66 MICROMINERALS & THEIR FUNCTIONS 150 TABLE 67 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 151 TABLE 68 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 151 TABLE 69 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 152 TABLE 70 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 152 8.11 OTHER TYPES 152 TABLE 71 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 153 TABLE 72 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 154 TABLE 73 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 154 TABLE 74 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 154 9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM 155 9.1 INTRODUCTION 156 FIGURE 41 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (BY VALUE) 156 TABLE 75 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 157 TABLE 76 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 157 9.2 DRY 157 9.2.1 BETTER STABILITY AND EASE OF HANDLING 157 TABLE 77 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 158 TABLE 78 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 158 9.3 LIQUID 158 9.3.1 LIMITED APPLICATIONS COMPARED TO DRY FORM 158 TABLE 79 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 159 TABLE 80 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 159 10 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 160 10.1 INTRODUCTION 161 FIGURE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (VALUE) 161 TABLE 81 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 162 TABLE 82 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 162 10.2 FOOD 162 TABLE 83 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 163 TABLE 84 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 163 10.2.1 SNACKS 163 10.2.1.1 Inclination toward protein-rich foods 163 10.2.2 CONFECTIONERY 164 10.2.2.1 Nutraceutical ingredients enhance texture, stability, and flavor 164 10.2.3 BAKERY 164 10.2.3.1 Adding omega-3 fatty acids lowers baking defects 164 10.2.4 DAIRY 165 10.2.4.1 Rising consumer awareness of health advantages of dairy products 165 10.2.5 MEAT & MEAT PRODUCTS 166 10.2.5.1 Major source of protein 166 10.2.6 BABY FOOD 166 10.2.6.1 High standards of living and preference for convenience foods 166 TABLE 85 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS 167 TABLE 86 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS 167 10.2.7 OTHERS 167 FIGURE 43 GLOBALLY RISING IMPORTS AND EXPORTS OF CEREALS AND CEREAL PRODUCTS, 2016–2020 168 TABLE 87 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2017–2021 (USD MILLION) 168 TABLE 88 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2022–2027 (USD MILLION) 169 10.3 BEVERAGES 169 TABLE 89 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 170 TABLE 90 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 170 10.3.1 ENERGY DRINKS 170 10.3.1.1 Offer specific medical and health benefits 170 10.3.2 JUICES 171 10.3.2.1 Functional benefits and growing health concerns 171 10.3.3 HEALTH DRINKS 171 10.3.3.1 Improves quality by reducing health risks 171 TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2017–2021 (USD MILLION) 172 TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2022–2027 (USD MILLION) 172 10.4 PERSONAL CARE 172 10.4.1 PREFERENCE FOR ORGANIC PERSONAL CARE PRODUCTS. 172 TABLE 93 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 173 TABLE 94 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 174 10.5 ANIMAL NUTRITION 174 10.5.1 RISING ANIMAL HEALTH AND NUTRITION MARKET 174 TABLE 95 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 175 TABLE 96 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 175 10.6 DIETARY SUPPLEMENTS 176 10.6.1 OFFER SEVERAL HEALTH BENEFITS 176 TABLE 97 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 177 TABLE 98 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 177 11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 178 11.1 INTRODUCTION 179 TABLE 99 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 179 TABLE 100 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 180 FIGURE 44 REGIONAL SNAPSHOT: US ACQUIRED LARGEST SHARE IN NUTRACEUTICAL INGREDIENTS MARKET, 2021 180 11.2 NORTH AMERICA 181 TABLE 101 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 181 TABLE 102 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 181 TABLE 103 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 182 TABLE 104 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 182 TABLE 105 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 183 TABLE 106 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 183 TABLE 107 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 183 TABLE 108 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 184 11.2.1 US 184 11.2.1.1 Improved quality of livestock-based products amid increased consumer demand 184 TABLE 109 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 185 TABLE 110 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 185 11.2.2 CANADA 186 11.2.2.1 Increased government support for R&D 186 FIGURE 45 CANADA: OVERWEIGHT OR OBESE, BY AGE GROUP AND SEX, 2018 187 TABLE 111 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 187 TABLE 112 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 188 11.2.3 MEXICO 188 11.2.3.1 Growing health and wellness trends 188 FIGURE 46 MEXICO: PER CAPITA EXPENDITURE ON FOOD, 2010–2018 188 TABLE 113 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 189 TABLE 114 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 190 11.3 EUROPE 190 TABLE 115 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 191 TABLE 116 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 191 TABLE 117 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 192 TABLE 118 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 192 TABLE 119 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 193 TABLE 120 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 193 TABLE 121 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 193 TABLE 122 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 193 11.3.1 GERMANY 194 11.3.1.1 Multiple applications of nutraceuticals in food & beverages and personal care products. 194 TABLE 123 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 195 TABLE 124 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 195 11.3.2 FRANCE 196 11.3.2.1 Increased health awareness and strategic government initiatives 196 TABLE 125 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 197 TABLE 126 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 197 11.3.3 UK 198 11.3.3.1 High demand for nutraceutical ingredients from food & beverage industry 198 TABLE 127 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 199 TABLE 128 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 199 11.3.4 ITALY 200 11.3.4.1 Increased consumption of food supplements 200 TABLE 129 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 200 TABLE 130 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 201 11.3.5 SPAIN 201 11.3.5.1 Preference for functional food and beverages 201 TABLE 131 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 202 TABLE 132 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 202 11.3.6 RUSSIA 203 11.3.6.1 Complicated and expensive registration process 203 TABLE 133 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 203 TABLE 134 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 204 11.3.7 REST OF EUROPE 204 TABLE 135 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 205 TABLE 136 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 205 11.4 ASIA PACIFIC 206 FIGURE 47 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, 2021 207 TABLE 137 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 207 TABLE 138 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 208 TABLE 139 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 208 TABLE 140 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 209 TABLE 141 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 209 TABLE 142 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 210 TABLE 143 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 210 TABLE 144 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 210 11.4.1 CHINA 210 11.4.1.1 Changing lifestyles of consumers 210 TABLE 145 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 212 TABLE 146 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 212 11.4.2 JAPAN 213 11.4.2.1 Preference for fortified foods over conventional ones 213 TABLE 147 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 214 TABLE 148 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 214 11.4.3 INDIA 215 11.4.3.1 High consumer demand due to rising hospitalization costs 215 TABLE 149 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 216 TABLE 150 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 216 11.4.4 AUSTRALIA & NEW ZEALAND 217 11.4.4.1 Preference for low-calorie foods to prevent chronic conditions 217 TABLE 151 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 218 TABLE 152 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 218 11.4.5 REST OF ASIA PACIFIC 219 TABLE 153 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 220 TABLE 154 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 220 11.5 SOUTH AMERICA 221 TABLE 155 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 221 TABLE 156 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 221 TABLE 157 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 222 TABLE 158 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 222 TABLE 159 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 223 TABLE 160 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 223 TABLE 161 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 223 TABLE 162 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 224 11.5.1 BRAZIL 224 11.5.1.1 Rising health consciousness and rapid urbanization 224 TABLE 163 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 225 TABLE 164 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 225 11.5.2 ARGENTINA 226 11.5.2.1 Affinity toward healthy foods and functional beverages 226 FIGURE 48 PREVALENCE OF UNDERNOURISHMENT IN ARGENTINA, 2012–2019 226 TABLE 165 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 227 TABLE 166 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 227 11.5.3 REST OF SOUTH AMERICA 228 TABLE 167 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 228 TABLE 168 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 229 11.6 REST OF THE WORLD (ROW) 229 TABLE 169 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 230 TABLE 170 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 230 TABLE 171 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 230 TABLE 172 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 231 TABLE 173 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 231 TABLE 174 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 232 TABLE 175 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 232 TABLE 176 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 232 11.6.1 MIDDLE EAST 232 11.6.1.1 Increased demand for healthy foods amid rising health concerns 232 TABLE 177 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 233 TABLE 178 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 234 11.6.2 AFRICA 234 11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals 234 TABLE 179 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 235 TABLE 180 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 236 12 COMPETITIVE LANDSCAPE 237 12.1 OVERVIEW 237 12.2 MARKET SHARE ANALYSIS, 2021 237 TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION (COMPETITIVE) 238 12.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS 238 FIGURE 49 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2017–2021 (USD BILLION) 238 12.4 STRATEGIES ADOPTED BY KEY PLAYERS 239 12.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 242 12.5.1 STARS 242 12.5.2 EMERGING LEADERS 242 12.5.3 PERVASIVE PLAYERS 242 12.5.4 PARTICIPANTS 243 FIGURE 50 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS) 243 12.5.5 PRODUCT FOOTPRINT 244 TABLE 182 COMPANY FOOTPRINT, BY TYPE 244 TABLE 183 COMPANY FOOTPRINT, BY APPLICATION 245 TABLE 184 COMPANY FOOTPRINT, BY REGION 246 TABLE 185 OVERALL COMPANY FOOTPRINT 247 12.6 NUTRACEUTICAL INGREDIENTS MARKET: EVALUATION QUADRANT FOR START-UPS/SMES, 2021 248 12.6.1 PROGRESSIVE COMPANIES 248 12.6.2 STARTING BLOCKS 248 12.6.3 RESPONSIVE COMPANIES 248 12.6.4 DYNAMIC COMPANIES 248 FIGURE 51 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (START-UPS/SME) 249 12.6.5 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 250 TABLE 186 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES 250 TABLE 187 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 251 12.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 253 12.7.1 PRODUCT LAUNCHES 253 TABLE 188 NUTRACEUTICAL INGREDIENTS: PRODUCT LAUNCHES, 2018–2022 253 12.7.2 DEALS 256 TABLE 189 NUTRACEUTICAL INGREDIENTS: DEALS, 2018–2022 256 12.7.3 OTHERS 269 TABLE 190 NUTRACEUTICAL INGREDIENTS: OTHERS, 2019-2022 269
SummaryThe market for nutraceutical ingredients is estimated at USD 185.2 Billion in 2022; it is projected to grow at a CAGR of 7.2% to reach USD 261.7 Billion by 2027. Nutraceutical ingredients are substances that are used to improve health, prevent chronic diseases, increase life expectancy, slow the aging process, or support the body’s systems. Nutraceutical ingredients are viewed as more of a preventive measure than a cure. Because these ingredients work on specific problems, they are frequently used as an ingredient in the formulation of products. Industries like food, beverage, dietary supplement, animal nutrition, and personal care are some of the most applied in their product formulation. These products are becoming more popular in the market due to their nutritional benefits and compatibility with people’s lifestyles. Immunity boosters, bone & health, cardiovascular health, mental wellness, infant nutrition, weight loss management, and other nutraceutical products are currently popular. People’s awareness of health and holistic wellness has grown over the last few years. The fast-paced lifestyle of the majority of the population influenced the rise in the nutraceutical ingredient market as people began looking for alternative’s nutrition. Table of Contents1 INTRODUCTION 381.1 STUDY OBJECTIVES 38 1.2 MARKET DEFINITION 38 1.3 STUDY SCOPE 39 1.3.1 MARKETS COVERED 39 FIGURE 1 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT 39 1.3.2 GEOGRAPHIC SEGMENTATION 40 FIGURE 2 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 40 1.4 INCLUSIONS & EXCLUSIONS 40 1.5 YEARS CONSIDERED 41 1.6 CURRENCY CONSIDERED 41 TABLE 1 US DOLLAR EXCHANGE RATES CONSIDERED, 2013–2018 42 1.7 UNIT CONSIDERED 42 1.8 STAKEHOLDERS 42 1.9 SUMMARY OF CHANGES 43 2 RESEARCH METHODOLOGY 44 2.1 RESEARCH DATA 44 FIGURE 3 NUTRACEUTICAL INGREDIENTS: RESEARCH DESIGN 44 2.1.1 SECONDARY DATA 45 2.1.1.1 Key data from secondary sources 45 2.1.2 PRIMARY DATA 45 2.1.2.1 Key industry insights 46 2.1.2.2 Breakdown of primary interviews 46 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46 2.2 MARKET SIZE ESTIMATION 47 2.2.1 BOTTOM-UP 47 FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 48 2.2.2 TOP-DOWN 48 FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 49 2.2.3 SUPPLY-SIDE 49 FIGURE 7 DATA TRIANGULATION: SUPPLY-SIDE 50 2.2.4 DEMAND-SIDE 50 FIGURE 8 DATA TRIANGULATION: DEMAND-SIDE 51 2.3 DATA TRIANGULATION 52 FIGURE 9 DATA TRIANGULATION 52 2.4 RESEARCH ASSUMPTIONS & LIMITATIONS 53 2.4.1 ASSUMPTIONS 53 2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS 54 3 EXECUTIVE SUMMARY 55 TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT, 2022 VS. 2027 55 FIGURE 10 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION) 56 FIGURE 11 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION) 57 FIGURE 12 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (USD BILLION) 57 FIGURE 13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 58 4 PREMIUM INSIGHTS 59 4.1 ATTRACTIVE OPPORTUNITIES IN NUTRACEUTICAL INGREDIENTS MARKET 59 FIGURE 14 INCREASED CONSUMPTION OF FORTIFIED FOODS DUE TO GROWING HEALTH CONSCIOUSNESS AMONG CONSUMERS 59 4.2 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY 60 FIGURE 15 INDIA AND PROBIOTICS ACCOUNTED FOR LARGEST SHARES, BY COUNTRY AND TYPE, RESPECTIVELY 60 4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SUBMARKETS 60 FIGURE 16 JAPAN TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 60 4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION 61 FIGURE 17 ASIA PACIFIC TO DOMINATE NUTRACEUTICAL INGREDIENTS MARKET ACROSS ALL TYPES 61 4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM 62 FIGURE 18 DRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 62 4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 62 FIGURE 19 DIETARY SUPPLEMENTS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 62 5 MARKET OVERVIEW 63 5.1 INTRODUCTION 63 5.2 MACROECONOMIC INDICATORS 63 5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY 63 5.2.2 KEY FACTS 63 5.2.2.1 Aging population becoming more aware of benefits of nutraceuticals 64 FIGURE 20 US POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION) 65 FIGURE 21 AGING POPULATION IN JAPAN, 2014–2018 65 5.3 MARKET DYNAMICS 66 FIGURE 22 NUTRACEUTICAL INGREDIENTS: MARKET DYNAMICS 66 5.3.1 DRIVERS 66 5.3.1.1 Growing demand for fortified food due to increased health consciousness among consumers 66 FIGURE 23 CONSUMERS' PERCEPTION REGARDING WHAT TO CONSUME OR AVOID 68 5.3.1.2 Increase in incidences of chronic diseases 68 FIGURE 24 PERCENTAGE OF US POPULATION WITH MULTIPLE CHRONIC ILLNESSES, 2017 69 FIGURE 25 CHRONIC DISEASES MOST PREVALENT WORLDWIDE AMONGST ALL AGES, 2019 69 FIGURE 26 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS 70 5.3.1.3 Mandates on food fortification by government organizations 71 TABLE 3 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION 72 TABLE 4 WIDELY USED FORTIFIED FOODS 73 FIGURE 27 NUMBER OF COUNTRIES WITH MANDATORY OR VOLUNTARY FOOD FORTIFICATION, 2021 73 5.3.2 RESTRAINTS 74 5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption 74 5.3.3 OPPORTUNITIES 75 5.3.3.1 Innovations in nutraceutical ingredients industry 75 5.3.3.2 Consumer awareness of micronutrient deficiencies 77 TABLE 5 FOODS TO BOOST IMMUNE SYSTEM 78 TABLE 6 MICRONUTRIENTS DEFICIENCY CONDITIONS AND THEIR WORLDWIDE PREVALENCE 78 5.3.4 CHALLENGES 78 5.3.4.1 Consumer skepticism associated with nutraceutical products 78 6 INDUSTRY TRENDS 80 6.1 INTRODUCTION 80 6.2 VALUE CHAIN ANALYSIS 81 FIGURE 28 VALUE CHAIN: NUTRACEUTICAL INGREDIENTS MARKET 81 6.2.1 SOURCING OF RAW MATERIALS 81 6.2.2 MANUFACTURING 82 6.2.3 DISTRIBUTION, MARKETING, AND SALES 82 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82 FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL INGREDIENTS MARKET 82 6.4 TECHNOLOGY ANALYSIS 83 6.4.1 FOOD MICROENCAPSULATION 83 6.4.1.1 Encapsulation of omega-3 to mask the odor 83 6.4.2 INNOVATIVE AND DISRUPTIVE TECH 84 6.4.2.1 Robotics leading to innovations in market 84 6.4.2.2 3D printing to uplift dietary supplements market 84 6.4.2.3 Hologram Sciences—platform for personalized nutrition and advice 84 6.5 PRICING ANALYSIS 85 FIGURE 30 PRICING ANALYSIS, 2017–2022 (USD/KG) 85 6.6 PATENT ANALYSIS 85 FIGURE 31 PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021 86 FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021 86 TABLE 7 KEY PATENTS PERTAINING NUTRACEUTICAL INGREDIENTS MARKET, 2021 87 6.7 MARKET MAP 88 6.7.1 UPSTREAM 88 6.7.1.1 Ingredient Manufacturers 88 6.7.1.2 Technology Providers 88 6.7.1.3 Start-ups/Emerging Companies 88 6.7.2 DOWNSTREAM 89 6.7.2.1 Regulatory Bodies 89 6.7.2.2 End Users 89 FIGURE 33 NUTRACEUTICALS INGREDIENTS MARKET MAP 90 TABLE 8 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM 90 6.8 TRADE SCENARIO 92 FIGURE 34 VITAMINS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 92 TABLE 9 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2021 (VALUE) 93 FIGURE 35 VITAMINS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 93 TABLE 10 EXPORT DATA ON VITAMINS FOR KEY COUNTRIES, 2021 (VALUE) 94 FIGURE 36 AMINO ACIDS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 94 TABLE 11 IMPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE) 95 FIGURE 37 AMINO ACIDS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 95 TABLE 12 EXPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE) 96 6.9 KEY CONFERENCES & EVENTS IN 2022–2023 96 TABLE 13 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2022–2023 96 6.10 TARIFF AND REGULATORY LANDSCAPE 98 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 6.10.2 REGULATORY FRAMEWORK 102 6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market 102 TABLE 19 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE 103 6.10.2.2 North America 104 6.10.2.2.1 Canada 104 6.10.2.2.2 US 104 6.10.2.2.3 Mexico 104 6.10.2.3 European Union (EU) 104 6.10.2.4 Asia Pacific 105 6.10.2.4.1 Japan 105 6.10.2.4.2 China 105 6.10.2.4.3 India 105 6.10.2.4.4 Australia & New Zealand 105 6.10.2.5 Rest of the World (RoW) 106 6.10.2.5.1 Israel 106 6.10.2.5.2 Brazil 106 6.10.2.6 Probiotics 106 6.10.2.6.1 Introduction 106 6.10.2.6.2 National/International bodies for safety standards and regulations 106 TABLE 20 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE 106 6.10.2.6.3 Codex Alimentarius Commission (CAC) 107 6.10.2.6.4 North America: Regulatory environment analysis 107 6.10.2.6.5 Europe: Regulatory environment analysis 108 6.10.2.6.6 Asia Pacific: Regulatory environment analysis 109 6.10.2.6.7 South America: Regulatory environment analysis 110 6.10.2.7 Prebiotics 110 6.10.2.7.1 Introduction 110 6.10.2.7.2 Asia Pacific 110 TABLE 21 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015 111 6.10.2.7.3 North America 111 TABLE 22 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES 112 6.10.2.7.4 European Union 113 6.11 PORTER'S FIVE FORCES ANALYSIS 113 TABLE 23 NUTRACEUTICAL INGREDIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS 113 6.11.1 DEGREE OF COMPETITION 113 6.11.2 BARGAINING POWER OF SUPPLIERS 114 6.11.3 BARGAINING POWER OF BUYERS 114 6.11.4 THREAT OF SUBSTITUTES 114 6.11.5 THREAT OF NEW ENTRANTS 115 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 115 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 115 FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES 116 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES (%) 116 6.12.2 BUYING CRITERIA 116 TABLE 25 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 116 FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 117 6.13 CASE STUDY ANALYSIS 117 6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY 117 6.13.2 MINDRIGHT’S BARS HELP COMBAT MENTAL HEALTH ISSUES 118 7 NUTRACEUTICAL INGREDIENTS MARKET, BY HEALTH BENEFITS 119 7.1 INTRODUCTION 119 7.2 COGNITIVE HEALTH 119 7.3 GUT HEALTH 120 7.4 HEART HEALTH 120 7.5 BONE HEALTH 121 TABLE 26 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE 121 7.6 IMMUNITY 122 7.7 NUTRITION 122 7.8 WEIGHT MANAGEMENT 122 7.9 OTHERS 123 8 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE 124 8.1 INTRODUCTION 125 FIGURE 40 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (BY VALUE) 125 TABLE 27 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 126 TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 126 TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (KT) 127 TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (KT) 127 8.2 PROBIOTIC 128 8.2.1 HIGH DEMAND FOR SCIENTIFICALLY PROVEN HEALTH FOODS AND DIETARY SUPPLEMENTS 128 TABLE 31 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 130 TABLE 32 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 130 TABLE 33 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 130 TABLE 34 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 131 8.3 PROTEINS & AMINO ACIDS 131 8.3.1 IMPORTANT INGREDIENTS IN FOOD AND FEED INDUSTRIES 131 TABLE 35 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 133 TABLE 36 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 133 TABLE 37 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 133 TABLE 38 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 134 8.4 PHYTOCHEMICALS & PLANT EXTRACTS 134 8.4.1 GROWING DEMAND FOR ORGANIC FOOD PRODUCTS AND INGREDIENTS 134 TABLE 39 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS 135 TABLE 40 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 135 TABLE 41 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 135 TABLE 42 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 136 TABLE 43 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 136 8.5 FIBERS & SPECIALTY CARBOHYDRATES 136 8.5.1 ADDED TO FUNCTIONAL FOOD & BEVERAGES MORE FREQUENTLY 136 TABLE 44 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 137 TABLE 45 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 138 TABLE 46 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 138 TABLE 47 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 138 8.6 OMEGA-3 FATTY ACIDS 139 8.6.1 INCREASED USE OF OMEGA-3 TO ENHANCE HEART AND BRAIN HEALTH 139 TABLE 48 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 140 TABLE 49 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 140 TABLE 50 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 140 TABLE 51 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 141 8.7 VITAMINS 141 8.7.1 AWARENESS, WIDE ACCEPTANCE, AND EASY AVAILABILITY DRIVE DEMAND 141 TABLE 52 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 142 TABLE 53 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 142 TABLE 54 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 143 TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 143 8.8 PREBIOTICS 143 8.8.1 USED AS TEXTURE ENHANCEMENT AND SWEETENING AGENTS 143 TABLE 56 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 144 TABLE 57 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 145 TABLE 58 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 145 TABLE 59 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 145 8.9 CAROTENOIDS 146 8.9.1 GROWING FOOD ADDITIVES AND PERSONAL CARE INDUSTRIES TO PROPEL DEMAND 146 TABLE 60 SOURCES OF CAROTENOIDS IN FRUIT AND VEGETABLES AND THEIR MEDICINAL PROPERTIES 147 TABLE 61 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 147 TABLE 62 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 148 TABLE 63 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 148 TABLE 64 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 148 8.10 MINERALS 149 8.10.1 SEVERAL HEALTH ADVANTAGES ASSOCIATED WITH MINERALS 149 TABLE 65 MACROMINERALS & THEIR FUNCTIONS 150 TABLE 66 MICROMINERALS & THEIR FUNCTIONS 150 TABLE 67 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 151 TABLE 68 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 151 TABLE 69 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 152 TABLE 70 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 152 8.11 OTHER TYPES 152 TABLE 71 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 153 TABLE 72 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 154 TABLE 73 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 154 TABLE 74 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 154 9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM 155 9.1 INTRODUCTION 156 FIGURE 41 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (BY VALUE) 156 TABLE 75 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 157 TABLE 76 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 157 9.2 DRY 157 9.2.1 BETTER STABILITY AND EASE OF HANDLING 157 TABLE 77 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 158 TABLE 78 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 158 9.3 LIQUID 158 9.3.1 LIMITED APPLICATIONS COMPARED TO DRY FORM 158 TABLE 79 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 159 TABLE 80 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 159 10 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 160 10.1 INTRODUCTION 161 FIGURE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (VALUE) 161 TABLE 81 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 162 TABLE 82 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 162 10.2 FOOD 162 TABLE 83 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 163 TABLE 84 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 163 10.2.1 SNACKS 163 10.2.1.1 Inclination toward protein-rich foods 163 10.2.2 CONFECTIONERY 164 10.2.2.1 Nutraceutical ingredients enhance texture, stability, and flavor 164 10.2.3 BAKERY 164 10.2.3.1 Adding omega-3 fatty acids lowers baking defects 164 10.2.4 DAIRY 165 10.2.4.1 Rising consumer awareness of health advantages of dairy products 165 10.2.5 MEAT & MEAT PRODUCTS 166 10.2.5.1 Major source of protein 166 10.2.6 BABY FOOD 166 10.2.6.1 High standards of living and preference for convenience foods 166 TABLE 85 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS 167 TABLE 86 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS 167 10.2.7 OTHERS 167 FIGURE 43 GLOBALLY RISING IMPORTS AND EXPORTS OF CEREALS AND CEREAL PRODUCTS, 2016–2020 168 TABLE 87 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2017–2021 (USD MILLION) 168 TABLE 88 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2022–2027 (USD MILLION) 169 10.3 BEVERAGES 169 TABLE 89 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 170 TABLE 90 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 170 10.3.1 ENERGY DRINKS 170 10.3.1.1 Offer specific medical and health benefits 170 10.3.2 JUICES 171 10.3.2.1 Functional benefits and growing health concerns 171 10.3.3 HEALTH DRINKS 171 10.3.3.1 Improves quality by reducing health risks 171 TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2017–2021 (USD MILLION) 172 TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2022–2027 (USD MILLION) 172 10.4 PERSONAL CARE 172 10.4.1 PREFERENCE FOR ORGANIC PERSONAL CARE PRODUCTS. 172 TABLE 93 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 173 TABLE 94 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 174 10.5 ANIMAL NUTRITION 174 10.5.1 RISING ANIMAL HEALTH AND NUTRITION MARKET 174 TABLE 95 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 175 TABLE 96 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 175 10.6 DIETARY SUPPLEMENTS 176 10.6.1 OFFER SEVERAL HEALTH BENEFITS 176 TABLE 97 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 177 TABLE 98 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 177 11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 178 11.1 INTRODUCTION 179 TABLE 99 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 179 TABLE 100 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 180 FIGURE 44 REGIONAL SNAPSHOT: US ACQUIRED LARGEST SHARE IN NUTRACEUTICAL INGREDIENTS MARKET, 2021 180 11.2 NORTH AMERICA 181 TABLE 101 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 181 TABLE 102 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 181 TABLE 103 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 182 TABLE 104 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 182 TABLE 105 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 183 TABLE 106 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 183 TABLE 107 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 183 TABLE 108 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 184 11.2.1 US 184 11.2.1.1 Improved quality of livestock-based products amid increased consumer demand 184 TABLE 109 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 185 TABLE 110 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 185 11.2.2 CANADA 186 11.2.2.1 Increased government support for R&D 186 FIGURE 45 CANADA: OVERWEIGHT OR OBESE, BY AGE GROUP AND SEX, 2018 187 TABLE 111 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 187 TABLE 112 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 188 11.2.3 MEXICO 188 11.2.3.1 Growing health and wellness trends 188 FIGURE 46 MEXICO: PER CAPITA EXPENDITURE ON FOOD, 2010–2018 188 TABLE 113 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 189 TABLE 114 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 190 11.3 EUROPE 190 TABLE 115 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 191 TABLE 116 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 191 TABLE 117 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 192 TABLE 118 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 192 TABLE 119 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 193 TABLE 120 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 193 TABLE 121 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 193 TABLE 122 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 193 11.3.1 GERMANY 194 11.3.1.1 Multiple applications of nutraceuticals in food & beverages and personal care products. 194 TABLE 123 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 195 TABLE 124 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 195 11.3.2 FRANCE 196 11.3.2.1 Increased health awareness and strategic government initiatives 196 TABLE 125 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 197 TABLE 126 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 197 11.3.3 UK 198 11.3.3.1 High demand for nutraceutical ingredients from food & beverage industry 198 TABLE 127 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 199 TABLE 128 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 199 11.3.4 ITALY 200 11.3.4.1 Increased consumption of food supplements 200 TABLE 129 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 200 TABLE 130 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 201 11.3.5 SPAIN 201 11.3.5.1 Preference for functional food and beverages 201 TABLE 131 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 202 TABLE 132 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 202 11.3.6 RUSSIA 203 11.3.6.1 Complicated and expensive registration process 203 TABLE 133 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 203 TABLE 134 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 204 11.3.7 REST OF EUROPE 204 TABLE 135 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 205 TABLE 136 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 205 11.4 ASIA PACIFIC 206 FIGURE 47 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, 2021 207 TABLE 137 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 207 TABLE 138 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 208 TABLE 139 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 208 TABLE 140 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 209 TABLE 141 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 209 TABLE 142 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 210 TABLE 143 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 210 TABLE 144 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 210 11.4.1 CHINA 210 11.4.1.1 Changing lifestyles of consumers 210 TABLE 145 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 212 TABLE 146 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 212 11.4.2 JAPAN 213 11.4.2.1 Preference for fortified foods over conventional ones 213 TABLE 147 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 214 TABLE 148 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 214 11.4.3 INDIA 215 11.4.3.1 High consumer demand due to rising hospitalization costs 215 TABLE 149 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 216 TABLE 150 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 216 11.4.4 AUSTRALIA & NEW ZEALAND 217 11.4.4.1 Preference for low-calorie foods to prevent chronic conditions 217 TABLE 151 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 218 TABLE 152 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 218 11.4.5 REST OF ASIA PACIFIC 219 TABLE 153 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 220 TABLE 154 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 220 11.5 SOUTH AMERICA 221 TABLE 155 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 221 TABLE 156 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 221 TABLE 157 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 222 TABLE 158 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 222 TABLE 159 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 223 TABLE 160 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 223 TABLE 161 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 223 TABLE 162 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 224 11.5.1 BRAZIL 224 11.5.1.1 Rising health consciousness and rapid urbanization 224 TABLE 163 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 225 TABLE 164 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 225 11.5.2 ARGENTINA 226 11.5.2.1 Affinity toward healthy foods and functional beverages 226 FIGURE 48 PREVALENCE OF UNDERNOURISHMENT IN ARGENTINA, 2012–2019 226 TABLE 165 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 227 TABLE 166 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 227 11.5.3 REST OF SOUTH AMERICA 228 TABLE 167 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 228 TABLE 168 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 229 11.6 REST OF THE WORLD (ROW) 229 TABLE 169 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 230 TABLE 170 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 230 TABLE 171 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 230 TABLE 172 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 231 TABLE 173 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 231 TABLE 174 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 232 TABLE 175 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 232 TABLE 176 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 232 11.6.1 MIDDLE EAST 232 11.6.1.1 Increased demand for healthy foods amid rising health concerns 232 TABLE 177 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 233 TABLE 178 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 234 11.6.2 AFRICA 234 11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals 234 TABLE 179 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 235 TABLE 180 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 236 12 COMPETITIVE LANDSCAPE 237 12.1 OVERVIEW 237 12.2 MARKET SHARE ANALYSIS, 2021 237 TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION (COMPETITIVE) 238 12.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS 238 FIGURE 49 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2017–2021 (USD BILLION) 238 12.4 STRATEGIES ADOPTED BY KEY PLAYERS 239 12.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 242 12.5.1 STARS 242 12.5.2 EMERGING LEADERS 242 12.5.3 PERVASIVE PLAYERS 242 12.5.4 PARTICIPANTS 243 FIGURE 50 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS) 243 12.5.5 PRODUCT FOOTPRINT 244 TABLE 182 COMPANY FOOTPRINT, BY TYPE 244 TABLE 183 COMPANY FOOTPRINT, BY APPLICATION 245 TABLE 184 COMPANY FOOTPRINT, BY REGION 246 TABLE 185 OVERALL COMPANY FOOTPRINT 247 12.6 NUTRACEUTICAL INGREDIENTS MARKET: EVALUATION QUADRANT FOR START-UPS/SMES, 2021 248 12.6.1 PROGRESSIVE COMPANIES 248 12.6.2 STARTING BLOCKS 248 12.6.3 RESPONSIVE COMPANIES 248 12.6.4 DYNAMIC COMPANIES 248 FIGURE 51 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (START-UPS/SME) 249 12.6.5 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 250 TABLE 186 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES 250 TABLE 187 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 251 12.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 253 12.7.1 PRODUCT LAUNCHES 253 TABLE 188 NUTRACEUTICAL INGREDIENTS: PRODUCT LAUNCHES, 2018–2022 253 12.7.2 DEALS 256 TABLE 189 NUTRACEUTICAL INGREDIENTS: DEALS, 2018–2022 256 12.7.3 OTHERS 269 TABLE 190 NUTRACEUTICAL INGREDIENTS: OTHERS, 2019-2022 269
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(ケミカル)の最新刊レポートMarketsandMarkets社のその他分野での最新刊レポート
本レポートと同じKEY WORD(acids)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/20 10:28 158.95 円 165.20 円 201.28 円 |